Clinical trial startup ProofPilot raises $12M to expand its reach
ProofPilot has raised $12 million in a funding round. The American startup focused on clinical trials will use the money to expand its reach. ProofPilot, a clinical trials startup based in New York, has announced a $12 million Series B fundraising round. The round was led by Mitsui & Co., with participation from Sopris Capital, First Trust Capital Partners, Excelra, and others. According to a source, this latest round of fundraising takes the company's overall funding round to around $15.7 million. The company developed a software-as-a-service research platform that it claims can assist companies and researchers in conducting trials on "regulated and non-regulated products and services" without the requirement for internal infrastructure. The startup , which was founded in 2014, is focused on assisting research institutions in designing trials, engaging patients, integrating with apps, and sharing data. In 2020, the company will collaborate with...